{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:16:04Z","timestamp":1768421764365,"version":"3.49.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["VHRM"],"DOI":"10.2147\/vhrm.s22591","type":"journal-article","created":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T21:06:05Z","timestamp":1323637565000},"page":"749","source":"Crossref","is-referenced-by-count":11,"title":["Differential clinical profile of candesartan compared to other angiotensin receptor blockers"],"prefix":"10.2147","author":[{"given":"Reuven","family":"Zimlichman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,12]]},"container-title":["Vascular Health and Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=11591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:21:09Z","timestamp":1477851669000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/differential-clinical-profile-of-candesartan-compared-to-other-angiote-peer-reviewed-article-VHRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/vhrm.s22591","relation":{},"ISSN":["1178-2048"],"issn-type":[{"value":"1178-2048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}